Clinical Breast Cancer
Publisher: Elsevier · ISSN 1526-8209 · 39 articles
- Prevention and Management of Radiation-Associated Fibrosis in Breast Cancer: A Practical, Stage-Based Approach
- Isolated Sternal Involvement in Breast Cancer: Is it Truly Stage IV Disease?
- Validity of Post-Neoadjuvancy Sentinel Lymph Node Biopsy in Patients with Clinical Tumor Staging T4 and/or N2 Breast Cancer
- Neoadjuvant Endocrine Therapy for Invasive Lobular Carcinoma: Balancing Positive Margins Against Breast Conservation Outcomes
- Association between preoperative prognostic nutritional index and the risk of recurrence or metastasis after modified radical mastectomy for breast cancer: a single-center retrospective cohort study
- Advances in Breast Cancer Sentinel Lymph Node Localization Modalities: A Systematic Review
- Is it the biology or the nodes? Molecular subtype is not associated with differential outcomes after post-mastectomy radiotherapy in SUPREMO-eligible breast cancer: a retrospective SEER cohort study
- Actionable PIK3CA Pathway Genomic Alterations in Breast Cancer in Young Women
- A retrospective study on the effectiveness of breast cancer detection based on ultrasound screening with supplemental mammography in Haidian District, Beijing
- Patient-reported outcomes in women undergoing preoperative breast MRI: a multicentre prospective cohort study
- Exploratory Evaluation of Radiology Report Embeddings and Mammographic Radiomics for Post-Cryoablation Biopsy and Biopsy-Proven Ipsilateral Breast Tumor Recurrence
- Cosmetic outcomes with three hypofractionated adjuvant radiotherapy schedules in patients with breast cancer
- Triple-Negative Breast Cancer heterogeneity: extracellular matrix, immune evasion, and therapeutic resistance landscape
- 2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice—Commentary Based on a Virtual Focus Group
- Incidence and Treatment Patterns of Pleomorphic Lobular Carcinoma in Situ: A Population-based Analysis After the Introduction of ICD-O-3 Code 8519/2
- Core Outcome Set Measures Are Underreported in Breast Cancer Randomized Clinical Trials: A Cross-Sectional Study
- Value of Breast and Axillary Tumor-Infiltrating Lymphocytes for Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast Cancer
- Prognostic Value of Baseline Metabolic Tumor Volume on [18F]FDG PET/CT in Metastatic Breast Cancer Treated With CDK4/6 Inhibitors
- Clinical Utility of [18F]Fluoroestradiol PET/CT to Guide Second Line Treatment Decision in ER-Positive HER2-Negative Metastatic Breast Cancer After Progression on First Line Endocrine Therapy
- Ketamine Versus Magnesium Sulphate as Adjuvants to Bupivacaine in Pectoral Nerve Blocks for Mastectomy: A Randomized, Double-Blind Trial
- Early On-Treatment Ultrasound Tumor Shrinkage and HER2-Positive Residual Invasive Disease After Neoadjuvant Therapy: A 2-Center Study
- Evaluating Physician Perspectives on Neoadjuvant Immunotherapy and Chemotherapy for Early-Stage Triple-Negative Breast Cancer
- Feasibility and Outcomes of Concomitant Boost in Prone Hypofractionated Whole-Breast Irradiation Using 3D-Conformal Radiotherapy
- Increasing Specialty Menopause Referrals for Premenopausal Breast Cancer Patients: A Quality Improvement Initiative
- The Immunomodulatory Effect of Various Anesthetic Factors and Techniques on Patients Undergoing Breast Cancer Surgery: A Systematic Review and Meta-analyses of RCTs
- Beyond the Small Incision: The Value of Endoscopic and Robotic Mastectomy
- Re-excision in Ductal Carcinoma In Situ: Comment on Dorten et al., “Re-excision in Ductal Carcinoma In Situ Is Not Associated With Improved Local Control”
- Risk factors and management of breast lymphoedema after breast-conserving treatment: a scoping review
- Late-Course Adjuvant Radiotherapy Concurrent with CDK4/6 Inhibitor for High-risk Breast Cancer: A Single -Center Randomized Controlled Trial Study
- Diagnostic Performance of Post-Neoadjuvant MRI for Breast Pathologic Complete Response in BRCA1/2 Pathogenic-Variant Carriers